Skip to main content
Computational and Structural Biotechnology Journal logoLink to Computational and Structural Biotechnology Journal
. 2022 Jan 6;20:545–558. doi: 10.1016/j.csbj.2021.12.038

Whole-genome analysis of carbapenem-resistant Acinetobacter baumannii from clinical isolates in Southern Thailand

Arnon Chukamnerd a, Kamonnut Singkhamanan a, Virasakdi Chongsuvivatwong b, Prasit Palittapongarnpim c, Yohei Doi d,e, Rattanaruji Pomwised f, Chanida Sakunrang g, Kongpop Jeenkeawpiam g, Mingkwan Yingkajorn h, Sarunyou Chusri a,i,, Komwit Surachat g,j,
PMCID: PMC9582705  PMID: 36284706

Graphical abstract

graphic file with name ga1.jpg

Keywords: Carbapenem-resistant Acinetobacter baumannii (CRAB), Whole-genome sequencing (WGS), Bioinformatics tool, Sequence type (ST), Antimicrobial resistance (AMR) gene, Mobile genetic element (MGE)

Abstract

The worldwide spread of carbapenem-resistant Acinetobacter baumannii (CRAB) has become a healthcare challenge for some decades. To understand its molecular epidemiology in Southern Thailand, we conducted whole-genome sequencing (WGS) of 221 CRAB clinical isolates. A comprehensive bioinformatics analysis was performed using several tools to assemble, annotate, and identify sequence types (STs), antimicrobial resistance (AMR) genes, mobile genetic elements (MGEs), and virulence genes. ST2 was the most prevalent ST in the CRAB isolates. For the detection of AMR genes, almost all CRAB isolates carried the blaOXA-23 gene, while certain isolates harbored the blaNDM-1 or blaIMP-14 genes. Also, various AMR genes were observed in these CRAB isolates, particularly aminoglycoside resistance genes (e.g., armA, aph(6)-Id, and aph(3″)-Ib), fosfomycin resistance gene (abaF), and tetracycline resistance genes (tet(B) and tet(39)). For plasmid replicon typing, RepAci1 and RepAci7 were the predominant replicons found in the CRAB isolates. Many genes encoding for virulence factors such as the ompA, adeF, pgaA, lpxA, and bfmR genes were also identified in all CRAB isolates. In conclusion, most CRAB isolates contained a mixture of AMR genes, MGEs, and virulence genes. This study provides significant information about the genetic determinants of CRAB clinical isolates that could assist the development of strategies for improved control and treatment of these infections.

1. Introduction

Multidrug resistance (MDR) in Gram-negative bacteria is a global public health concern as the treatment options are dramatically limited [1], [2]. These pathogens have a high level of resistance to available antimicrobial classes, especially carbapenems and colistin, which are considered to be the last-line treatments [3], [4], [5]. Among them, carbapenem-resistant Acinetobacter baumannii (CRAB) is an important cause of nosocomial infections associated with high mortality rates [6]. It is commonly transmitted in intensive care units (ICUs). CRAB can cause various infections such as ventilator-associated pneumonia, wound infections, urinary tract infections (UTIs), bloodstream infections, and meningitis [7], [8].

CRAB can be resistant to carbapenems through various mechanisms. Carbapenemase production is the major mechanism of carbapenem resistance in A. baumannii as well as other Gram-negative bacteria. The carbapenemase enzymes have been classified by Ambler into three classes, class A, class B, and class D carbapenemases [9]. The carbapenemase-encoding genes are mainly located on mobile genetic elements (MGEs), plasmids, transposons, and integrons. Due to the presence of MGEs, many carbapenemase genes can be transferred between plasmids and chromosomes. Additionally, they can be horizontally transferred from one bacteria to another bacteria, leading to the rapid dissemination of carbapenemase genes [10]. Although the genetic basis associated with antimicrobial resistance (AMR) and bacterial pathogenesis among CRAB isolates has been characterized [11], [12]. The genetic processes supporting the co-acquisition of multiple carbapenemase genes as well as other AMR genes still need to be elucidated further. Whole-genome sequencing (WGS) has become a powerful tool for rapidly analyzing the entire genomic DNA sequence of organisms. It has been used to characterize and understand the mechanisms of AMR and their spread through bacterial species, which is necessary for combating AMR-bacteria [13], [14].

Previously, most of the studies have been reported the genetic characteristics of CRAB clinical isolates from many countries such as Korea, Thailand, Vietnam, Myanmar, Malaysia, and Brazil as well as in European countries [1], [3], [15], [16], [17], [18]. Their findings demonstrated that a high level of the CRAB isolates was assigned to an ST2 with the carriage of the blaOXA-23 gene and other AMR genes conferring resistance to many antibiotic classes, particularly aminoglycosides. In addition, the RecAci1 plasmid was predominantly found in the CRAB isolates, while the insertion sequence (IS) elements (e.g., ISAba1 and ISAba125) were also detected in the CRAB isolates. Although several studies have provided WGS data of many CRAB isolates which are for understanding the distribution of AMR genes, virulence genes, and MGEs, there are to date few studies examining the genomic characteristics of CRAB isolates from Southern Thailand. Elucidation of the mechanisms of acquired AMR genes and virulence-associated genes and the genomic diversity among the CRAB isolates would help better understand their dissemination patterns in the regions. This is because CRAB isolates continuously evolve to survive in harsh environments, and they have been spreading throughout the world for a long time. Importantly, the AMR genes can be horizontally transferred (conjugation and transduction) to other related pathogenic bacteria, causing the rapid and global spread of AMR in Gram-negative bacteria. Thus, the objective of this study was to analyze the whole-genome sequence of CRAB, isolated from patients in 7 hospitals within lower Southern Thailand, to gain genomic insights into the clinical CRAB isolates of this area. The understanding and tracing of the rapid evolution of MDR in Gram-negative bacteria will play an important role in controlling these bacteria and slowing their spread until more effective treatments become available.

2. Materials and methods

2.1. Bacterial isolates and clinical data

In this study, a total of 221 CRAB isolates were obtained from the Clinical Microbiology Laboratories (CMLs) of 7 hospitals located in lower Southern Thailand including Trang Hospital (n = 62; 28.05%), Songklanagarind Hospital (n = 54; 24.43%), Phatthalung Hospital (n = 45; 20.36%), Songkhla Hospital (n = 44; 19.91%), Satun Hospital (n = 7; 3.17%), Pattani Hospital (n = 7; 3.17%), and Yala Hospital (n = 2; 0.90%) (Fig. 1a). The 221 CRAB isolates were collected mostly from sputum but also from other clinical specimens (e.g., urine, pus, blood, body fluids, and tissue) of 221 patients who were admitted to the hospitals between March and August 2019 (Fig. 1b). In CMLs, the A. baumannii strains were identified by biochemical tests, according to Bergey's Manual of Systematic Bacteriology [19] and confirmed by Matrix-Assisted Laser Desorption/Ionization-Time Of Flight (MALDI-TOF) mass spectrometry (MS) [20], [21]. The phenotypic resistance to carbapenem (imipenem and meropenem) in A. baumannii strains was evaluated by disk diffusion method. A. baumannii strains were defined as resistant to carbapenem, when the zone diameters were ≤ 18 mm for imipenem and/or ≤ 14 mm for meropenem, according to the CLSI guideline (2018) [22]. The inclusion criterion for CRAB isolates was the A. baumannii strains that were resistant to carbapenem, while A. baumannii strains without carbapenem resistance were excluded from the study.

Fig. 1.

Fig. 1

The numbers of CRAB clinical isolates collected at hospitals located in 6 provinces, lower Southern Thailand (a) and sample sources (b). TR, Trang Hospital; PSU, Songklanagarind Hospital; PT, Phatthalung Hospital; SK, Songkhla Hospital; ST, Satun Hospital; PA, Pattani Hospital; YL, Yala Hospital; NA, not available.

2.2. Genome library preparation and sequencing

Genomic DNA of all the CRAB isolates was extracted using the TIANamp Bacterial DNA Kit (Tiangen, Beijing, China), following the manufacturer’s instructions. The extracted DNA was sent to the Beijing Genomics Institute (BGI) in China for short-read WGS. For testing sample qualification, the DNA concentrations were measured by Qubit Fluorometer (Invitrogen), while DNA integrity and purity were investigated by Agarose Gel Electrophoresis. Then, 1 µg of the qualified genomic DNA (≥23 kbp) was randomly fragmented by Covaris. Fragmented sequences with a size of ≤ 800 bp were selected using the Agencourt AMPure XP-Medium kit. End-repair and 3′-adenylation were performed on the fragments, and adaptors were ligated to the ends of these 3′-adenylated fragments to amplify the fragments. The PCR products were then purified using an Agencourt AMPure XP-Medium kit. The double-stranded PCR products were heat-denatured and circularized by the splint oligo sequence. The single-strand circle DNA (ssCir DNA) was formatted as the final library. The quality of the whole-genome library was checked by quality control (QC). The qualified libraries were sequenced by BGISEQ-500 (BGI, China). Finally, 150-bp paired-end reads were received by combinatorial Probe-Anchor Synthesis (cPAS).

2.3. Genome assembly and annotation

De novo assemblies of our 221 CRAB genomes were generated using SPAdes v3.12 [23]. The quality and completeness of the genome assemblies were assessed by Quast v5.0.2 [24] and Busco v5.1.2 [25], [26], respectively. According to the exploration of reported A. baumannii genomes in the National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/), we predicted that the highest length of A. baumannii genomes is approximate 4.4 Mbp. Thus, assembled sequences containing a read length of > 4.4 Mbp were initially excluded from the study, because they might contain contaminant sequences from other species. The genomes were then annotated using Prokka v1.12 [27], and finally, the tRNAs and rRNAs were identified by tRNAscan-SE v2.0 [28], [29] and RNAmmer v1.2 [30], respectively.

2.4. Bioinformatics analysis

Sequence analyses were performed using several bioinformatics tools. Although the CMLs of the 7 hospitals had previously identified the CRAB isolates using standard biochemical methods and MALDI-TOF MS, the A. baumannii species was reconfirmed by in silico methods using SpeciesFinder v2.0 (https://cge.cbs.dtu.dk/services/SpeciesFinder/) [31] in the center for genomic epidemiology (CGE). For multilocus sequence typing (MLST), we searched the sequence types (STs) of all CRAB isolates against the public databases for molecular typing and microbial genome diversity (PubMLST) using mlst v2.19.0 (https://github.com/tseemann/mlst) [32]. The AMR genes were identified using ABRicate v1.0.1 (https://github.com/tseemann/abricate) with the default parameter against the comprehensive antibiotic resistance database (CARD) (https://card.mcmaster.ca/) [33]. In plasmid identification, we created a plasmid nucleotide sequence database based on the literature reviews [16], [34], [35], [36], [37], [38], [39], [40], [41], [42] and then predicted the presence of plasmid replicon types using blastn v2.12.0 with 80% identity and 1e-30 E-value cut-offs. The presence of insertion sequence (IS) elements was predicted using ABRicate v1.0.1 with the default parameter against the IS database from ISfinder (https://www-is.biotoul.fr/) [43]. Also, the integrons were investigated using integron_finder v2.0 (https://github.com/gem-pasteur/Integron_Finder) with the default parameter [44]. Also, the virulence-associated genes were detected using blastn v2.12.0 with 80% identity and 1e-30 E-value cut-offs against the virulence factor database (VFDB) of Acinetobacter spp. (http://www.mgc.ac.cn/cgi-bin/VFs/genus.cgi?Genus=Acinetobacter) [45], while the bacteriocin-encoding genes were explored using blastx v2.12.0 with 80% identity and 1e-30 E-value cut-offs against the databases from bacteriocin genome mining tool (BAGEL4) (http://bagel4.molgenrug.nl/databases.php) [46]. We also predicted the presence of the bacteriophage genome in the CRAB isolates using phigaro v2.3.0 (https://github.com/bobeobibo/phigaro) with the default parameter [47].

2.5. Pan-genome and phylogenetic analysis

The pan-genome of our 221 CRAB isolates was analyzed using Roary v3.13.0 [48], with a 95% minimum blastp identity and a 99% core definition threshold. Then, we called SNPs of core genes to reduce the computational complexity for phylogenetic tree construction using SNP-sites v2.4.1 [49]. Afterward, a phylogenetic tree was then built by raxmlHPC-PTHREADS v8.2.12 with the neighbor-joining method using 1000 bootstraps [50]. Visualization of the phylogenetic tree was performed using Geneious R10.26 [51] and Phandango website (https://jameshadfield.github.io/phandango/) [52]. A pan-genome frequency plot, a piechart of the pan-genome, and a presence and absence matrix against a phylogenetic tree were created using roary_plots script (https://github.com/sanger-pathogens/Roary/tree/master/contrib/roary_plots). In addition, we also performed the pan-genome analysis of our CRAB genomes compared to previously published genomes from Thailand [16]. The phylogenetic trees were constructed based on the SNPs of core genes and accessory genes, respectively, with the neighbor-joining method using 1000 bootstraps.

3. Results

3.1. Patient demographics and clinical profiles

Since we selected only 1 isolate per patient for performing WGS, the prevalence and distribution of patients in each hospital were equal to the number of isolates, as noted earlier. The clinical profiles showed that, in the 221 patients infected with CRAB, diabetes mellitus was the most common underlying disease (n = 103; 46.61%), followed by hypertension (n = 78; 35.29%), chronic kidney disease (n = 48; 21.72%), cerebrovascular disease (n = 42; 19.00%), coronary artery disease (n = 38; 17.19%), and pulmonary disease (n = 29; 13.12%). Importantly, 199 (90.04%) of the 221 patients had previously received carbapenem antibiotics (meropenem, imipenem, and/or ertapenem). We found the prior use of ceftriaxone, piperacillin-tazobactam, fluoroquinolones (levofloxacin or ciprofloxacin), ceftazidime, and aminoglycosides (amikacin or gentamicin) in 139 (62.90%), 116 (52.49%), 77 (34.84%), 27 (12.22%), and 27 (12.22%) patients. The previous use of other antibiotics (azithromycin, colistin, tigecycline, or cefoperazone-sulbactam) was also found in some patients. The metadata of the patients is shown in Table S1.

3.2. Genome assembly quality

In the 221 CRAB isolates, de novo assembly yielded genome lengths from 3,777,937 bp to 4,319,283 bp, with an average of 3,930,367 bp. The number of contigs ranged from 26 to 193, with an average of 68. The GC-content varied from 38.68% to 39.10%, with an average of 38.91%. The N50 and L50 values of the 221 assembled genomes ranged from 45,197 bp to 444,207 bp having an average of 175,941 bp and 3 to 28 having an average of 9, respectively. The details of the assembly quality are given in Table S2.

3.3. Sequence types (STs) and antimicrobial resistance (AMR) determinants

In the MLST results of the 221 CRAB isolates (Table S3), ST2 had the largest frequency having been identified in 119 (53.85%) isolates, followed by ST164 (n = 29; 13.12%), ST374 (n = 18; 8.14%), ST16 (n = 13; 5.88%), ST215 (n = 12; 5.43%), and so forth. However, STs could not be assigned for 2 (0.90%) isolates, PSU043 and PSU114. Among the 7 housekeeping genes of A. baumannii, using MLST (Pasteur), the alignment of PSU043 genome with allele 8 of the recA gene showed 99.73% identity and 100% coverage. This PSU043 contained 1 nucleotide substitution (A to G) at position 99 of the recA gene sequence, resulting in a non-identified ST, while PSU114 provided 100% identity and 100% coverage in alignment with all 7 genes. However, when the locus combination of allele 181 of the gltA gene and the alleles of the 6 other genes were analyzed, according to the MLST allelic profile, PSU114 could not be assigned to an ST.

Identification of AMR determinants from the WGS data revealed various AMR determinants with the predicted resistance to several antimicrobial classes, as shown in Fig. 2, Fig. 3, Table S4. Among the 221 CRAB isolates, 207 (93.66%) isolates carried the blaOXA-23 gene, while only 18 (8.14%), 8 (3.62%), and 1 (0.45%) isolates harbored the blaNDM-1, blaOXA-58, and blaIMP-14 genes, respectively. These genes were the carbapenemase genes that might be expressed, leading to carbapenem resistance in these CRAB isolates. Likewise, we found the blaOXA-66 (n = 133; 60.18%), blaADC-73 (n = 109; 49.32%), blaTEM-12 (n = 58; 26.24%), blaOXA-91 (n = 35; 15.84%), blaADC-79 (n = 27; 12.22%), and blaCARB-16 (n = 27; 12.22%) genes and so forth, which may provide resistance to other β-lactam antibiotics such as penicillins and cephalosporins. For aminoglycoside resistance prediction, the armA, aph(6)-Id, and aph(3″)-Ib genes were highly detected in 153 (69.23%), 149 (67.42%), and 146 (66.06%) isolates, respectively. Additionally, we found more aminoglycoside resistance genes such as the aph(3′)-Ia (n = 82; 37.10%), ant(2″)-Ia (n = 22; 9.95%), ant(3″)-IIa (n = 22; 9.95%), and aac(6′)-Ib7 (n = 19; 8.60%) genes, and so forth. Notably, the abaF gene that probably provides resistance to fosfomycin was present in 208 (94.12%) isolates. In addition, 176 (79.64%) isolates possessed the mphE and msrE genes predicting macrolide resistance, while 124 (56.11%) and 54 (24.43%) isolates contained the tet(B) and tet(39) genes predicting tetracycline resistance. The sul2 and sul1 genes that may confer resistance to sulfonamide were observed in 102 (46.15%) and 30 (13.57%) isolates, respectively. We also found other genes such as the arr-2 (n = 20; 9.05%) and catB8 (n = 18; 8.14%) genes, which may provide resistance to rifampicin and chloramphenicol, respectively. Besides the investigation of the presence of AMR genes, almost all CRAB isolates might be classified as MDR isolates since they possessed many genes that probably confer resistance to more than three antimicrobial classes.

Fig. 2.

Fig. 2

Distribution of antimicrobial resistance (AMR) genes in the study 221 CRAB clinical isolates according to sequence types (STs). NI, non-identified ST; AMG, aminoglycoside; FQ, fluoroquinolone; FOS, fosfomycin; RF, rifampicin; TET, tetracycline; CPL, chloramphenicol; TMP, trimethoprim; SF, sulfonamide; LC, lincosamide; MC, macrolide.

Fig. 3.

Fig. 3

Fig. 3

The presence of antimicrobial resistance (AMR) genes in the study 221 CRAB clinical isolates. Red, pink, orange, dark blue, light blue, purple, dark gold, blue, dark green, solid bracken green, black, and green colors represent the predicted resistance to β-lactam, aminoglycoside, aminoglycoside and fluoroquinolone, fluoroquinolone, fosfomycin, rifampicin, tetracycline, chloramphenicol, trimethoprim, sulfonamide, lincosamide, and macrolide, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

In terms of the ST distribution of AMR genes in the 221 CRAB isolates, we found that all ST2 isolates harbored the blaOXA-23 and blaOXA-66 genes (Fig. 2, Fig. 3, Table S4). ST2 isolates carried various AMR genes, ranging from 5 to 19 in number. In addition, some AMR genes, especially the aph(3″)-Ib, aph(6)-Id, armA, abaF, sul2, mphE, and msrE genes were detected in many STs. The blaOXA-69 and blaADC-11 genes were only present in ST1 isolate (PT007), while the blaOXA-417 and blaVEB-7 genes were only found in ST396 isolate (SK070). The blaIMP-14, blaADC-68, aac(6′)-Ib-cr, qnrB17, and dfrA27 genes were only identified in ST433 isolate (SK066), while the blaOXA-67 and aac(6′)-Ib9 genes were only seen in ST740 isolate (PSU104). Also, only ST25 isolates possessed the aac(3)-IIe and aac(6′)-Ian genes, while only ST113 isolates harbored the aph(3′)-VIa gene.

3.4. Mobile genetic elements (MGEs)

Overall, the plasmid replicons were identified in 219 (99.10%) of the CRAB isolates, while no plasmids were found in the other 2 (0.90%) isolates, PT041 and SK066. A total of 169 (76.47%) isolates contained 2 to 6 plasmid types, while 50 (22.62%) isolates carried only one plasmid, as shown in Fig. 4 and S1, Table S5. Notably, PT069 contained the highest number of plasmids, RepAci1, RepAci7, RepM-Aci9, p1ABSDF, pABTJ2, and pRAY*. The RepAci1 and RepAci7 plasmids were detected at a high frequency in 139 (62.90%) and 120 (54.30%) isolates, respectively, and they were present in almost all ST2 isolates. The RepM-Aci9 plasmid was harbored by 39 (17.65%) isolates, followed by RepApAB49 (n = 34; 15.38%), pABTJ2 (n = 26; 11.76%), p4ABAYE0001 (n = 21; 9.50%), and so forth. The pA297-3 plasmid was found in all ST25 isolates and the RepAci4 plasmid was present in three ST126 isolates.

Fig. 4.

Fig. 4

Distribution of mobile-genetic elements (MGEs) in the study 221 CRAB clinical isolates according to sequence types (STs). NI, non-identified ST; ISs, insertion sequences.

Besides plasmid identification, we also investigated insertion sequences (ISs) and integrons. For the ISs, we found that ISAba22 (n = 154; 69.68%) and ISEc29 (n = 153; 69.23%) were the most common ISs in the CRAB isolates. ISAba26, ISVsa3, ISAba1, and ISAba24 were detected in 141 (63.80%), 138 (62.44%), 119 (53.85%), and 114 (51.58%) isolates, respectively. ISAba11 was only detected in all ST25 isolates, while other ISs were distributed in several ST isolates. The IS results are illustrated in Fig. 4 and S1, Table S6.

For the integrons, the integron-associated intI1 gene was detected in 34 isolates (15.38%). The results also showed the arrangement of genes on integrons, particularly AMR genes. In 34 integron-positive isolates, 21 (61.76%), 2 (5.88%), and 1 (2.94%) isolates carried the aac(6′)-Ib, aac(3)-Ia, and blaIMP-14 genes on their integrons, respectively. Twenty (58.82%) isolates harbored an efflux pump gene on their integrons, which may provide chloramphenicol resistance, as shown in Fig. 4 and S1, Table S7.

3.5. Virulence-associated genes

The investigation of the virulence factors of Acinetobacter spp. in the CRAB isolates revealed the presence of virulence genes associated with adherence, biofilm formation, enzyme, immune evasion, iron uptake, regulation, and serum resistance. All isolates possessed genes encoding OmpA (outer membrane protein A), AdeFGH efflux pump, PANG (poly-N-acetylglucosamine), LPS (lipopolysaccharide), BfmRS (regulation of biofilm formation), and PbpG (penicillin-binding protein). A total of 220/221 (99.55%) isolates (except SK066) harbored all acinetobactin genes. Twenty-six to 29 virulence genes were identified in 220 of the isolates, while only 10 virulence genes were detected in SK066. Among the capsule-encoding genes that are responsible for immune evasion, all isolates carried ACICU_0071 (ATPase gene), ACICU_0092 (phosphomannomutase gene), and pgi genes. ACICU_0091 (UDP-glucose 4-epimerase gene), ACICU_0088 (UDP-glucose pyrophosphorylase gene), ACICU_0089 (UDP-glucose 6-dehydrogenase gene), ACICU_0074 (UDP-N-acetyl-D-mannosaminuronate dehydrogenase gene), and ACICU_0087 (sugar transferase gene) were mostly found in 215 (97.28%), 211 (95.48%), 179 (81.00%), 169 (76.47%), and 161 (72.85%) isolates. Likewise, the study showed that 219 (99.10%), 203 (91.86%) to 205 (92.76%), 197 (89.14%), 181 (81.90%) to 174 (78.73%), and 143 (64.71%) isolates possessed virulence factors including phospholipase D/C, Csu fimbriae, hemO cluster, quorum sensing, and biofilm-associated proteins, respectively. Virulence-associated gene information and results are shown in Fig. 5 and S2, Table S8.

Fig. 5.

Fig. 5

The presence of virulence-associated genes in the study 221 CRAB clinical isolates. OmpA, outer membrane protein A; Bap, biofilm-associated protein; PNAG, poly-N-acetylglucosamine; LPS, lipopolysaccharide; Bfm, biofilm formation; PbpG, penicillin-binding protein; ACICU_0071 to ACICU_0092 represent the genes encoding proteins related to the capsule (ACICU_0071, ATPase; ACICU_0072, protein-tyrosine-phosphatase; ACICU_0073, periplasmic protein; ACICU_0074, UDP-N-acetyl-D-mannosaminuronate dehydrogenase; ACICU_0075, nucleoside-diphosphate sugar epimerase; ACICU_0076, pyridoxal phosphate-dependent enzyme; ACICU_0077, CMP-N-acetylneuraminic acid synthetase; ACICU_0078, spore coat polysaccharide biosynthesis protein [glycosyltransferase]; ACICU_0079, acetyltransferase; ACICU_0080, sialic acid synthase; ACICU_0081, membrane protein; ACICU_0082 - ACICU_0085, hypothetical protein; ACICU_0086, glycosyltransferase; ACICU_0087, sugar transferase; ACICU_0088, UDP-glucose pyrophosphorylase; ACICU_0089, UDP-glucose 6-dehydrogenase; ACICU_0091, UDP-glucose 4-epimerase; ACICU_0092, phosphomannomutase).

3.6. Bacteriocin-encoding gene and bacteriophage genomes

In this study, we also explored the presence of bacteriocin and bacteriophages. For bacteriocin identification, the study showed that all CRAB isolates carried the zooA gene encoding zoocin A. In addition, we found the genome matching three phage families, belonging to the order Caudovirales in the prophage investigation. The Siphoviridae, Myoviridae, and Podoviridae families were seen in 212 (95.93%), 63 (28.51%), and 37 (16.74%) isolates, respectively. The bacteriocin-encoding gene and bacteriophage genome information is given in Fig. S2, Table S9.

3.7. Pan-genome and phylogenetic analysis

The results of pan-genome analysis among the study 221 CRAB isolates showed that 9,318 (68.68%), 2,412 (17.78%), 1,615 (11.90%), and 222 (1.64%) of 13,567 pan genes were identified as cloud, core, shell, and soft-core genes, respectively. These CRAB isolates contained various genes associated with transcriptional regulators and transporters in 3.96% and 4.19% of the pan-genome, respectively. Notably, we also found genes encoding transposases and bacteriophage proteins (e.g., heads, capsids, and tails) in 1.30% and 0.51% of the accessory genome. Furthermore, genes encoding hypothetical proteins were also observed in 5.97% and 66.44% of core and accessory genomes, respectively. Overall, the phylogenetic tree could be divided into many clades according to STs, as illustrated in Fig. 6 and S3. Among these clades, ST1479 was in the same clade as ST164. For two isolates that could not be assigned to an STs, one isolate was grouped into the ST374 clade, while the other isolate was located in the ST16 clade. Interestingly, we noticed that two isolates, SK066 and SK070, which were very different in terms of gene presence and absence, belonged to the different clades, as shown in the red box of Fig. S4. According to the gene presence and absence matrix (Fig. S4) and pan-genome graph (Fig. S5), the pan-genome profiles of these CRAB isolates seem to provide an open pan-genome with vast genomic diversity (Fig. S5).

Fig. 6.

Fig. 6

Phylogenetic tree constructed by calling SNPs from core gene alignment of the study 221 CRAB clinical isolates.

In addition, the results of pan-genome analysis of our 221 CRAB genomes compared to 188 previously published genomes are exhibited in Figs. S6 - S9. In 18,915 pan genes, 14,685 (77.64%), 2,282 (12.06%), 1,633 (8.63%), and 315 (1.67%) genes were detected as cloud, core, shell, and soft-core genes, respectively. Genes encoding transposases and bacteriophage proteins (e.g., heads, capsids, and tails) were observed in 2.78% and 0.49% of the accessory genome, respectively.

4. Discussion

The rapid increase of CRAB infections seriously threatens the global population. Since most CRAB isolates resist many potential antimicrobial classes, it is currently difficult, if not impossible, to manage CRAB infections, especially through the use of suitable antibiotics. Faced with these challenges, many scientists across the world are trying to characterize and understand the mechanisms of antimicrobial resistance in CRAB isolates. We therefore used WGS as a comprehensive method for studying and exploring the genetic basis of 221 CRAB isolates collected at hospitals in Southern Thailand.

According to the results of this study, the largest proportion of CRAB isolates was identified in ST2, which belonged to international clone 2 (IC2) [53], [54]. ST2 is the most predominant type and the most widespread in many parts of the world, especially Thailand [55], [56], [57]. The prevalences of other STs such as ST164, ST374, ST16, ST215, ST25 (IC7), ST129 (IC2), and ST1 (IC1) are different in each region [55], [56], [58], [59], [60]. Hamidian and Nigro (2019) reported the level ST of 3575 CRAB isolates showing ST2 as the most prevalent ST, followed most prominently by ST1 (IC1), ST76, SLV2 (a single-locus variant of ST2), ST25 (IC7), ST10, and then others with lower prevalences [56]. Here, we also noticed that 6 isolates belonged to ST1479, a new ST that was recently discovered in a clinical isolate of extensively drug-resistant A. baumannii (XDRAB) from Thailand [61]. Unfortunately, two isolates could not be assigned to an ST by PubMLST in this study. PSU043 contained one nucleotide substitution (A99G) in the recA gene, which is a silent mutation that does not cause an alteration of the amino acid. Therefore, we predicted that this mutation may not change the function of the RecA protein, and the nearest ST identified by the PubMLST was ST16. For PSU114, although there were no mutations in all seven housekeeping genes, we still could not identify the ST.

In the detection of AMR genes, a majority of the CRAB isolates possessed the blaOXA-23 gene, which is the distinctive class D carbapenemase-encoding gene in A. baumannii. It has been reported in many countries all over the world including the USA, Australia, Germany, Brazil, China, Korea, Thailand, Vietnam, Malaysia, Pakistan, and Egypt [1], [3], [15], [16], [17], [18], [55], [56], [62], [63]. Normally, oxacillinase (OXA) enzymes have a weak hydrolyzing activity and are poorly expressed, resulting in a low level of carbapenem resistance [56], [64]. Nevertheless, the blaOXA expression can be enhanced by an IS located upstream of the blaOXA genes, leading to a high level of carbapenem resistance [56], [65]. As to the results of our study, ISAba1 was identified in 56.04% of the blaOXA-23-positive CRAB isolates. Many earlier reports have demonstrated that ISAba1 is generally located upstream of the blaOXA-23-like gene, and it provides a strong promoter that drives the expression of the blaOXA-23-like gene [63], [66], [67], [68]. In addition, we found other blaOXA variants such as the blaOXA-58 gene. The OXA-58 enzyme has been reported with high-level resistance to carbapenem in A. baumannii [69]. More than half of our CRAB isolates also carried the blaOXA-66 gene, and some of the isolates harbored the blaOXA-91, blaOXA-259, and blaOXA-402 genes, and so forth. These genes are member of the blaOXA-51-like genes, the intrinsic oxacillinase genes with low-level carbapenemase activity that naturally occur and are located on the chromosome of A. baumannii [62], [65], [70], [71].

In addition, some of our CRAB isolates possessed class B carbapenemase (metallo-β-lactamase; MBL) genes including blaNDM-1 and blaIMP-14 genes. These MBL genes provide a broad spectrum of carbapenemase activity in Gram-negative bacteria, particularly Enterobacterales, Acinetobacter spp., and Pseudomonas aeruginosa [72]. Additionally, we found ISAba125 in 72.22% of the blaNDM-1-positive CRAB isolates. ISAba125 is commonly located upstream and provides a promoter sequence for the blaNDM-1 expression [73], [74]. We also found extended-spectrum β-lactamase (ESBL) genes (blaTEM-12, blaVEB-1, blaVEB-7, blaPER-1, and blaPER-7) and other β-lactamase genes (e.g., blaAmpC, blaADC-6, blaADC-30, blaADC-73, blaADC-79, blaCARB-16, ble, etc.). The blaAmpC and blaADC genes are the class C β-lactamase genes, while the blaCARB gene is a class A β-lactamase gene. Overproduction of AmpC β-lactamase in combination with ESBLs, efflux pumps, and/or porin loss has been associated with carbapenem resistance in Gram-negative bacteria [75], [76].

Besides β-lactam resistance genes, the other genes that probably confer resistance to aminoglycoside, fosfomycin, tetracycline, chloramphenicol, trimethoprim, sulfonamide, lincosamide, and macrolide were found in these CRAB isolates and they might be classified as multidrug-resistant (MDR) isolates accordingly. Many studies have reported on the retained susceptibility to aminoglycosides (e.g., amikacin and gentamicin) and tetracyclines (e.g., doxycycline and tigecycline) in carbapenem-resistant Gram-negative bacteria (CR-GNB) [74], [77], [78], [79]. Unfortunately, although aminoglycosides and tetracyclines are used as a monotherapy, or in combination with other antimicrobial agents against CR-GNB infection [77], [80], aminoglycosides seem more effective in carbapenem-resistant Enterobacteriaceae (CRE) than in CRAB, while tetracyclines are normally used to combat both CRE and CRAB [80]. The tigecycline resistance is continuously found in CRAB [78]. Notably, although low-level resistance to plazomicin, a novel aminoglycoside, has been reported in CRAB [80], we found that over a haft of the CRAB isolates carried the armA gene, which has been reported as confer high-level resistance to aminoglycosides, particularly gentamicin, amikacin, tobramycin, and plazomicin [81]. Our CRAB isolates also harbored other aminoglycoside resistance genes (aph(6)-Id, aph(3′)-Ia, aadA1, aac(3)-IId, ant(2″)-Ia, aac(6′)-lb, armA, etc.) and tetracycline resistance genes (tet(B) and tet(39)), a finding concordant with previous studies [82], [83]. As well, previous studies demonstrated good efficacy of fosfomycin in combination with other antibiotics against CR-GNB [74], [84], [85]. However, our findings showed that the abaF gene, a fosfomycin resistance gene, was seen in almost all CRAB isolates. This would indicate that aminoglycosides, tetracyclines, and fosfomycin should be used with caution for the treatment of CRAB infections. In addition, the mphE and msrE genes were present in a high number of the CRAB isolates. These genes commonly associated with MDR in A. baumannii, which confer resistance to macrolide by inactivation (mphE) and modification of the target site (msrE) [86], [87].

In our study on the dissemination mechanisms of the AMR gene among Gram-negative bacteria, we investigated the MGEs (plasmids, IS elements, and integrons). The findings showed that the largest number of CRAB isolates harbored the RepAci1 and RepAci7 plasmids. The RepAci1 plasmid is one of the most widespread plasmids in Acinetobacter spp. [88]. Towner et al. (2011) reported that the blaOXA-23-like and blaOXA-58-like genes were associated with the carriage of the repAci1 replicase gene located on the RepAci1 plasmid [71]. Surprisingly, here, we found a high prevalence of RepAci7 plasmid in these CRAB isolates, which has not been reported in any other countries. Loraine et al. (2020) previously analyzed the genomics of A. baumannii isolated from three hospitals located in Central and Southern Thailand. They found the RepAci1, RepAci6, and RepApAB49 plasmids to have a high frequencies, while the RepAci7 plasmid was not detected in any A. baumannii isolates. Additionally, plasmid pA297-3 was present in all ST25 isolates. This plasmid has been associated with the AMR spread in Acinetobacter spp., particularly in ST25 isolates [89]. Among the 61 ISs detected in our study, we found that ISAba22 was the most prevalent IS, followed by ISEc29, ISAba26, ISVsa3, ISAba1, and ISAba24. Besides functioning as the promoters for the expression of many AMR genes, the ISs generally provide for a cut-and-paste mechanism of transposition [90]. Previous studies have shown that the blaOXA-23 gene is mostly located in a composite transposon Tn2006 that is bracketed by two copies of ISAba1 [88], [90]. In terms of integrons, we found an integron-integrase gene (IntI1) in 34 CRAB isolates. The AMR genes, especially aminoglycoside resistance genes (aac(6′)-Ib and aac(3)-Ia), were present in the integron-encoded IntI1 integrase. The SK066 isolate carried the blaIMP-14 gene in the class 1 integron, similar to many other reports [91], [92]. According to the MGE results, we indicate that if the AMR genes locate on the MGEs, these particular genes might be horizontally transferred (conjugation) to other Acinetobacter spp. as well as other species of Gram-negative pathogenic bacteria. Thus, the MGEs are a significant factor in the acquisition and spread of AMR genes [93].

In addition to AMR, pathogenic bacteria have evolved and developed virulence to host-defense mechanisms [94], [95]. We found the virulence-associated genes encoding for many virulence factors (e.g., adherence, biofilm formation, enzyme, immune evasion, iron uptake, regulation, and serum resistance) in all CRAB isolates. This finding could imply that the presence of these virulence genes may increase the pathogenicity of these CRAB isolates and the severity of infection [95]. Importantly, they might be spread to other bacteria through horizontal gene transfer, similar to the AMR genes [94]. Furthermore, we found the zooA gene encoding zoocin A in all isolates. Zoocin A, a bacteriocin-like inhibitory substance (BLIS), was first identified in Streptococcus equi subsp. zooepidemicus strain 4881 [96], [97], [98]. It is a peptidoglycan hydrolase that is responsible for inhibiting the peptidoglycan synthesis in many other streptococcal species, especially S. mutans, S. sobrinus, and S. cricetus [96], [97], [98]. Importantly, it is also classified as a penicillin-binding protein (PBP) [96], which provides weak β-lactamase activity against penicillin. This might be one of the factors causing high-level β-lactam resistance in the CRAB isolates. In the investigation of the bacteriophage genome, a very high level of CRAB isolates showed sequence alignment to Siphoviridae phage, while some isolates also harbored Myoviridae and/or Podoviridae phages. These three phage families belong to the order Caudovirales, which contains double-stranded DNA (dsDNA) genomes [99]. We thus postulate that the CRAB isolates might have been previously infected by these particular phages. More importantly, the DNA phages can drive the bacterial genes, especially AMR genes, to other bacteria by generalized transduction [100], [101]. Thus, the discovery of these bacteriophage genomes within the CRAB genomes may be indicated as one of the factors causing the spread of AMR genes or other genes.

To demonstrate the genomic diversity, we analyzed the pan-genome among our 221 CRAB isolates. The pan-genome profiles showed that these CRAB isolates shared 17.78% core genes, and contained a very high percentage (68.68%) of cloud genes. In a presence and absence matrix of pan-genome, the accessory genome demonstrated the presence of genes encoding transposases and bacteriophage proteins (e.g., head, capsid, and tails), and the high level of genes encoding hypothetical proteins in these CRAB isolates. We hypothesized that these genes are probably involved in adaptation mechanisms, particularly the acquisition of AMR and virulence genes and the ability to persist in some changing environments [102], [103]. Based on our analysis, the pan-genome graph could be possibly considered as an open pan-genome since our dataset contained only 221 isolates. However, in the analysis of a larger dataset of A. baumannii isolates, the result also exhibited that exponential pan-genome growth was observed when increasing a great number of pan-genome [103], [104], [105], [106]. Furthermore, the high proportion of accessory genes demonstrated a high genomic diversity among these isolates. This discovery could be an indicator of a useful path for researchers to explore and perhaps find new genes and to study genomic diversity in the A. baumannii strains, especially carbapenem-resistant and MDR isolates. Notably, two isolates (SK066 and SK070) in our study were uncommon and very different from the other CRAB isolates. However, after submitting the genome sequences of 221 isolates into the NCBI server, the submission details reported that only 219 isolates were CRAB, whereas the other 2 isolates belonged to other Acinetobacter species. The average nucleotide identity (ANI) results from NCBI revealed that the SK066 and SK077 isolates were identified as Acinetobacter pittii (97.42% identity) and Acinetobacter nosocomialis (97.85% identity), respectively. These two isolates were previously confirmed as A. baumannii by both in vitro and in silico methods and also carried carbapenem resistance genes as well as other AMR genes. This could indicate that these genomes are biologically related among Acinetobacter spp. To further elucidate the genomic data of these two isolates, additional tools and technologies such as long-read WGS should be considered to provide more information in the future. In addition, the pan-genome analysis of our CRAB genomes compared to previously published genomes demonstrated that the specific features could not be observed among the accessory genomes. These findings could be indicated that genetic features of the A. baumannii clinical isolates from Thailand are closely related.

WGS provides more accurate details and more precise information than traditional microbiological methods; for example, in the comparison of antimicrobial susceptibility patterns obtained from antimicrobial susceptibility testing (AST) and bacterial DNA fingerprints obtained from pulse-field gel electrophoresis (PFGE) [107]. These strengths of this method allow scientists to compare entire genome sequences within the bacterial cell, for a better understanding of the epidemiology of the pathogens such as identifying the environmental source of an outbreak, transmission events, and the mechanism for spreading antimicrobial resistance [108], [109], [110]. Since the presence or absence of MGEs carrying AMR genes results in genetic variation and changes in antimicrobial susceptibility patterns, WGS can rapidly provide crucial data during an acute outbreak [111]. Therefore, using WGS to study the genomic insights into the pathogens, especially antibiotic-resistant strains, could be beneficial for outbreak investigations and surveillance as well as infection control and prevention.

5. Conclusions

This study revealed significant information from a short-read WGS analysis. All CRAB isolates possessed various AMR genes, MGEs (especially plasmids and ISs), and virulence-associated genes, which can be horizontally transferred to other pathogenic bacteria causing widespread carbapenem resistance. The bacteriocin gene and the bacteriophage genomes were present at the highest frequency in these CRAB isolates. Finally, a way to rapidly identify and characterize the genomic features of the CR-GNB strains is necessary before we will be able to finally control the spread of these pathogens in the future.

6. Data availability statement

The assembled genomes of all 221 CRAB isolates have been deposited in the NCBI GenBank under BioProject number PRJNA752484 with BioSample numbers SAMN20599216 to SAMN20599436.

Funding

This research was funded by the National Science and Technology Development Agency (NSTDA), Thailand (project number: P-20–51325) and the Graduate Scholarship, Faculty of Medicine, Prince of Songkla University, Thailand (grant number: 62-012). This study was also supported by the Faculty of Science, Prince of Songkla University, Thailand (grant number: SCI64040135).

Ethical approval

The study was approved by the Human Research Ethics Committee (HREC) of Prince of Songkla University (reference number: 64–284-14–1, date of approval: 9 June 2021).

CRediT authorship contribution statement

Arnon Chukamnerd: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Visualization, Project administration. Kamonnut Singkhamanan: Methodology, Resources, Writing – review & editing, Supervision, Funding acquisition. Virasakdi Chongsuvivatwong: Conceptualization, Data curation, Writing – review & editing, Supervision, Funding acquisition. Prasit Palittapongarnpim: Data curation, Writing – review & editing, Supervision. Yohei Doi: Writing – review & editing, Supervision. Rattanaruji Pomwised: Methodology, Resources, Writing – review & editing, Supervision. Chanida Sakunrang: Methodology, Validation, Investigation, Resources. Kongpop Jeenkeawpiam: Methodology, Software, Investigation, Resources. Mingkwan Yingkajorn: Resources, Funding acquisition. Sarunyou Chusri: Conceptualization, Methodology, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition. Komwit Surachat: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, Funding acquisition.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The authors are grateful to the Clinical Microbiology Laboratories (CMLs) in Songklanagarind Hospital, Songkhla Hospital, Phatthalung Hospital, Satun Hospital, Trang Hospital, Pattani Hospital, and Yala Hospital for providing the CRAB isolates. We acknowledge the Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University as well as the Division of Computational Science and the Molecular Evolution and Computational Biology (MECoB) Research Unit, Faculty of Science, Prince of Songkla University for use of their research facilities. Finally, we thank Miss Parita Boonnatee for constructing some figures and Mr. Dave Patterson for English language review in this study.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.csbj.2021.12.038.

Contributor Information

Kamonnut Singkhamanan, Email: skamonnu@medicine.psu.ac.th.

Virasakdi Chongsuvivatwong, Email: cvirasak@medicine.psu.ac.th.

Prasit Palittapongarnpim, Email: prasit.pal@mahidol.ac.th.

Rattanaruji Pomwised, Email: rattanaruji.p@psu.ac.th.

Mingkwan Yingkajorn, Email: mingkwan.y@psu.ac.th.

Sarunyou Chusri, Email: sarunyouchusri@hotmail.com.

Komwit Surachat, Email: komwit.s@psu.ac.th.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Supplementary data 1
mmc1.zip (8MB, zip)

References

  • 1.Kostyanev T., Xavier B.B., García-Castillo M., Lammens C., Acosta J.B.-F., et al. Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study. Int J Antimicrob Agents. 2021;57(6):106345. doi: 10.1016/j.ijantimicag.2021.106345. [DOI] [PubMed] [Google Scholar]
  • 2.Pogue J.M., Mann T., Barber K.E., Kaye K.S. Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev Anti Infect Ther. 2013;11(4):383–393. doi: 10.1586/eri.13.14. [DOI] [PubMed] [Google Scholar]
  • 3.Wareth G., Linde J., Nguyen N.H., Nguyen T.N., Sprague L.D., et al. WGS-based analysis of carbapenem-resistant Acinetobacter baumannii in Vietnam and molecular characterization of antimicrobial determinants and MLST in Southeast Asia. Antibiotics. 2021;10(5):563. doi: 10.3390/antibiotics10050563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pormohammad A., Mehdinejadiani K., Gholizadeh P., Nasiri M.J., Mohtavinejad N., et al. Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis. Microb Pathog. 2020;139 doi: 10.1016/j.micpath.2019.103887. [DOI] [PubMed] [Google Scholar]
  • 5.Theriault N., Tillotson G., Sandrock C.E. Global travel and Gram-negative bacterial resistance; implications on clinical management. Expert Rev Anti Infect Ther. 2021;19(2):181–196. doi: 10.1080/14787210.2020.1813022. [DOI] [PubMed] [Google Scholar]
  • 6.Centers for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report), CDC, Atlanta, GA. 2019. [Accessed 04 January 2020]; Available from: https://www.cdc.gov/drugresistance/Biggest-Threats.html.
  • 7.Ambrosi C., Scribano D., Aleandri M., Zagaglia C., Di Francesco L., et al. Acinetobacter baumannii virulence traits: a comparative study of a novel sequence type with other Italian endemic international clones. Front Microbiol. 2017;8:1977. doi: 10.3389/fmicb.2017.01977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cerqueira G.M., Peleg A.Y. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life. 2011;63(12):1055–1060. doi: 10.1002/iub.533. [DOI] [PubMed] [Google Scholar]
  • 9.Ambler R. The structure of β-lactamases. Phil Trans R Soc Lond B. 1980;289(1036):321–331. doi: 10.1098/rstb.1980.0049. [DOI] [PubMed] [Google Scholar]
  • 10.Voulgari E., Zarkotou O., Ranellou K., Karageorgopoulos D.E., Vrioni G., et al. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother. 2012;68(1):84–88. doi: 10.1093/jac/dks356. [DOI] [PubMed] [Google Scholar]
  • 11.Jiang L., Yu Y., Zeng W., Guo J., Lv F., et al. Whole-genome analysis of New Delhi Metallo-Beta-Lactamase-1-producing Acinetobacter haemolyticus from China. J Glob Antimicrob Resist. 2020;20:204–208. doi: 10.1016/j.jgar.2019.05.012. [DOI] [PubMed] [Google Scholar]
  • 12.Liu B.-T., Su W.-Q. Whole genome sequencing of NDM-1-producing serotype K1 ST23 hypervirulent Klebsiella pneumoniae in China. J Med Microbiol. 2019;68(6):866–873. doi: 10.1099/jmm.0.000996. [DOI] [PubMed] [Google Scholar]
  • 13.Mansour W., Grami R., Jaidane N., Messaoudi A., Charfi K., et al. Epidemiology and whole-genome analysis of NDM-1-producing Klebsiella pneumoniae KP3771 from Tunisia. Microb Drug Resist. 2019;25(5):644–651. doi: 10.1089/mdr.2018.0204. [DOI] [PubMed] [Google Scholar]
  • 14.Runcharoen C., Raven K.E., Reuter S., Kallonen T., Paksanont S., et al. Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand. Genome Med. 2017;9(1):81. doi: 10.1186/s13073-017-0471-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kim M.H., Jeong H., Sim Y.M., Lee S., Yong D., et al. Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications. PLoS ONE. 2020;15(2) doi: 10.1371/journal.pone.0229416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Loraine J., Heinz E., Soontarach R., Blackwell G.A., Stabler R.A., et al. Genomic and phenotypic analyses of Acinetobacter baumannii isolates from three tertiary care hospitals in Thailand. Front Microbiol. 2020;11:548. doi: 10.3389/fmicb.2020.00548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rao M., Rashid F.A., Shukor S., Hashim R., Ahmad N. Detection of antimicrobial resistance genes associated with carbapenem resistance from the whole-genome sequence of Acinetobacter baumannii isolates from Malaysia. Can J Infect Dis Med Microbiol. 2020;2020 doi: 10.1155/2020/5021064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Camargo C.H., Cunha M.P.V., de Barcellos T.A.F., Bueno M.S., de Jesus Bertani A.M., et al. Genomic and phenotypic characterisation of antimicrobial resistance in carbapenem-resistant Acinetobacter baumannii hyperendemic clones CC1, CC15, CC79 and CC25. Int J Antimicrob Agents. 2020;56(6) doi: 10.1016/j.ijantimicag.2020.106195. [DOI] [PubMed] [Google Scholar]
  • 19.Krieg N.R., Holt J.G. Yi Hsien Publishing Co; 1984. Bergey's manual of systematic bacteriology. [Google Scholar]
  • 20.Espinal P., Seifert H., Dijkshoorn L., Vila J., Roca I. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect. 2012;18(11):1097–1103. doi: 10.1111/j.1469-0691.2011.03696.x. [DOI] [PubMed] [Google Scholar]
  • 21.MarÝ-Almirall M, Cosgaya C, Higgins PG, Van Assche A, Telli M, et al. MALDI-TOF/MS identification of species from the Acinetobacter baumannii (Ab) group revisited: inclusion of the novel A. áseifertii and A. ádijkshoorniae species. Clin Microbiol Infect 2017;23(3):210.e1-210.e9. [DOI] [PubMed]
  • 22.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 28th ed; approved standard M100. CLSI, Wayne, PA. 2018.
  • 23.Bankevich A., Nurk S., Antipov D., Gurevich A.A., Dvorkin M., et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gurevich A., Saveliev V., Vyahhi N., Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics. 2013;29(8):1072–1075. doi: 10.1093/bioinformatics/btt086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Simão F.A., Waterhouse R.M., Ioannidis P., Kriventseva E.V., Zdobnov E.M. BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs. Bioinformatics. 2015;31(19):3210–3212. doi: 10.1093/bioinformatics/btv351. [DOI] [PubMed] [Google Scholar]
  • 26.Seppey M., Manni M., Zdobnov E.M. BUSCO: assessing genome assembly and annotation completeness. Methods Mol Biol (Clifton, NJ) 2019;1962:227–245. doi: 10.1007/978-1-4939-9173-0_14. [DOI] [PubMed] [Google Scholar]
  • 27.Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
  • 28.Chan PP, Lowe TM, tRNAscan-SE: searching for tRNA genes in genomic sequences. In Gene prediction (pp. 1-14). Humana, New York, NY. [DOI] [PMC free article] [PubMed]
  • 29.Lowe T.M., Chan P.P. tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res. 2016;44(W1):W54–W57. doi: 10.1093/nar/gkw413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lagesen K., Hallin P., Rødland E.A., Stærfeldt H.-H., Rognes T., et al. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007;35(9):3100–3108. doi: 10.1093/nar/gkm160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Larsen M.V., Cosentino S., Lukjancenko O., Saputra D., Rasmussen S., et al. Benchmarking of methods for genomic taxonomy. J Clin Microbiol. 2014;52(5):1529–1539. doi: 10.1128/JCM.02981-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jolley KA, Bray JE, Maiden MC. Open-access bacterial population genomics: BIGSdb software, the PubMLST. org website and their applications. Wellcome Open Res 2018;3:124. [DOI] [PMC free article] [PubMed]
  • 33.Alcock B.P., Raphenya A.R., Lau T.T., Tsang K.K., Bouchard M., et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 2020;48(D1):D517–D525. doi: 10.1093/nar/gkz935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bertini A., Poirel L., Mugnier P.D., Villa L., Nordmann P., et al. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother. 2010;54(10):4168–4177. doi: 10.1128/AAC.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Salto I.P., Tejerizo G.T., Wibberg D., Pühler A., Schlüter A., et al. Comparative genomic analysis of Acinetobacter spp. plasmids originating from clinical settings and environmental habitats. Sci Rep. 2018;8(1):1–12. doi: 10.1038/s41598-018-26180-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gao F., Wang Y., Liu Y.-J., Wu X.-M., Lv X., et al. Genome sequence of Acinetobacter baumannii MDR-TJ. J Bacteriol. 2011;193(9):365–2366. doi: 10.1128/JB.00226-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hamidian M., Nigro S.J., Hall R.M. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother. 2012;67(12):2833–2836. doi: 10.1093/jac/dks318. [DOI] [PubMed] [Google Scholar]
  • 38.Hamidian M., Ambrose S.J., Hall R.M. A large conjugative Acinetobacter baumannii plasmid carrying the sul2 sulphonamide and strAB streptomycin resistance genes. Plasmid. 2016;87:43–50. doi: 10.1016/j.plasmid.2016.09.001. [DOI] [PubMed] [Google Scholar]
  • 39.Zhang W.-J., Lu Z., Schwarz S., Zhang R.-M., Wang X.-M., et al. Complete sequence of the blaNDM-1-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother. 2013;68(7):1681–1682. doi: 10.1093/jac/dkt066. [DOI] [PubMed] [Google Scholar]
  • 40.Jones L.S., Toleman M.A., Weeks J.L., Howe R.A., Walsh T.R., et al. Plasmid carriage of blaNDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob Agents Chemother. 2014;58(7):4211–4213. doi: 10.1128/AAC.02500-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Blackwell G.A., Hall R.M. The tet39 determinant and the msrE-mphE genes in Acinetobacter plasmids are each part of discrete modules flanked by inversely oriented p dif (XerC-XerD) sites. Antimicrob Agents Chemother. 2017;61(8):e00780–17. doi: 10.1128/AAC.00780-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hamidian M., Nigro S.J., Hartstein R.M., Hall R.M. RCH51, a multiply antibiotic-resistant Acinetobacter baumannii ST103IP isolate, carries resistance genes in three plasmids, including a novel potentially conjugative plasmid carrying oxa235 in transposon Tn 6252. J Antimicrob Chemother. 2017;72(7):1907–1910. doi: 10.1093/jac/dkx069. [DOI] [PubMed] [Google Scholar]
  • 43.Siguier P., Pérochon J., Lestrade L., Mahillon J., Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(suppl_1):D32–D36. doi: 10.1093/nar/gkj014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cury J., Jové T., Touchon M., Néron B., Rocha E.P. Identification and analysis of integrons and cassette arrays in bacterial genomes. Nucleic Acids Res. 2016;44(10):4539–4550. doi: 10.1093/nar/gkw319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chen L., Yang J., Yu J., Yao Z., Sun L., et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 2005;33(suppl_1):D325–D328. doi: 10.1093/nar/gki008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.de Jong A., van Hijum S.A., Bijlsma J.J., Kok J., Kuipers O.P. BAGEL: a web-based bacteriocin genome mining tool. Nucleic Acids Res. 2006;34(suppl_2):W273–W279. doi: 10.1093/nar/gkl237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Starikova E.V., Tikhonova P.O., Prianichnikov N.A., Rands C.M., Zdobnov E.M., et al. Phigaro: high-throughput prophage sequence annotation. Bioinformatics. 2020;36(12):3882–3884. doi: 10.1093/bioinformatics/btaa250. [DOI] [PubMed] [Google Scholar]
  • 48.Page A.J., Cummins C.A., Hunt M., Wong V.K., Reuter S., et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31(22):3691–3693. doi: 10.1093/bioinformatics/btv421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Page A.J., Taylor B., Delaney A.J., Soares J., Seemann T., et al. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb Genom. 2016;2(4) doi: 10.1099/mgen.0.000056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30(9):1312–1313. doi: 10.1093/bioinformatics/btu033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kearse M., Moir R., Wilson A., Stones-Havas S., Cheung M., et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28(12):1647–1649. doi: 10.1093/bioinformatics/bts199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hadfield J., Croucher N.J., Goater R.J., Abudahab K., Aanensen D.M., et al. Phandango: an interactive viewer for bacterial population genomics. Bioinformatics. 2018;34(2):292–293. doi: 10.1093/bioinformatics/btx610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Levy-Blitchtein S., Roca I., Plasencia-Rebata S., Vicente-Taboada W., Velásquez-Pomar J., et al. Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru. Emerg Microbes Infect. 2018;7(1):1–9. doi: 10.1038/s41426-018-0127-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Giannouli M., Antunes L.C., Marchetti V., Triassi M., Visca P., et al. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis. 2013;13(1):1–11. doi: 10.1186/1471-2334-13-282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Eigenbrod T., Reuter S., Gross A., Kocer K., Günther F., et al. Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012–15. J Antimicrob Chemother. 2019;74(12):3473–3480. doi: 10.1093/jac/dkz360. [DOI] [PubMed] [Google Scholar]
  • 56.Hamidian M., Nigro S.J. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10) doi: 10.1099/mgen.0.000306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Thirapanmethee K., Srisiri-A-Nun T., Houngsaitong J., Montakantikul P., Khuntayaporn P., et al. Prevalence of OXA-Type β-Lactamase genes among carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand. Antibiotics. 2020;9(12):864. doi: 10.3390/antibiotics9120864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Cerezales M., Xanthopoulou K., Wille J., Bustamante Z., Seifert H., et al. Acinetobacter baumannii analysis by core genome multi-locus sequence typing in two hospitals in Bolivia: endemicity of international clone 7 isolates (CC25) Int J Antimicrob Agents. 2019;53(6):844–849. doi: 10.1016/j.ijantimicag.2019.03.019. [DOI] [PubMed] [Google Scholar]
  • 59.Caldart R.V., Fonseca E.L., Freitas F., Rocha L., Vicente A.C. Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016–2018. Mem Inst Oswaldo Cruz. 2019;114 doi: 10.1590/0074-02760190232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Shelenkov A., Petrova L., Zamyatin M., Mikhaylova Y., Akimkin V. Diversity of international high-risk clones of Acinetobacter baumannii revealed in a Russian multidisciplinary medical center during 2017–2019. Antibiotics. 2021;10(8):1009. doi: 10.3390/antibiotics10081009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chopjitt P., Wongsurawat T., Jenjaroenpun P., Boueroy P., Hatrongjit R., et al. Complete genome sequences of four extensively drug-resistant Acinetobacter baumannii isolates from Thailand. Microbiol Resour Announc. 2020;9(40):e00949–20. doi: 10.1128/MRA.00949-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Abouelfetouh A., Torky A.S., Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrob Resist Infect Control. 2019;8(1):1–9. doi: 10.1186/s13756-019-0611-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Khurshid M., Rasool M.H., Ashfaq U.A., Aslam B., Waseem M., et al. Dissemination of blaOXA-23-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. J Glob Antimicrob Resist. 2020;21:357–362. doi: 10.1016/j.jgar.2020.01.001. [DOI] [PubMed] [Google Scholar]
  • 64.Héritier C., Poirel L., Lambert T., Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(8):3198–3202. doi: 10.1128/AAC.49.8.3198-3202.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006;258(1):72–77. doi: 10.1111/j.1574-6968.2006.00195.x. [DOI] [PubMed] [Google Scholar]
  • 66.Khurshid M., Rasool M.H., Ashfaq U.A., Aslam B., Waseem M. Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan. Future Microbiol. 2017;12(14):1261–1269. doi: 10.2217/fmb-2017-0080. [DOI] [PubMed] [Google Scholar]
  • 67.Liu L.-L., Ji S.-J., Ruan Z., Fu Y., Fu Y.-Q., et al. Dissemination of blaOXA-23 in Acinetobacter spp. in China: main roles of conjugative plasmid pAZJ221 and transposon Tn2009. Antimicrob Agents Chemother. 2015;59(4):1998–2005. doi: 10.1128/AAC.04574-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lin M.-F., Kuo H.-Y., Yeh H.-W., Yang C.-M., Sung C.-H., et al. Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp. in a regional hospital in Taiwan. J Microbiol Immunol Infect. 2011;44(1):39–44. doi: 10.1016/j.jmii.2011.01.008. [DOI] [PubMed] [Google Scholar]
  • 69.Bertini A., Poirel L., Bernabeu S., Fortini D., Villa L., et al. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(7):2324–2328. doi: 10.1128/AAC.01502-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Héritier C., Poirel L., Fournier P.-E., Claverie J.-M., Raoult D., et al. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(10):4174–4179. doi: 10.1128/AAC.49.10.4174-4179.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Towner K.J., Evans B., Villa L., Levi K., Hamouda A., et al. Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D β-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(5):2154–2159. doi: 10.1128/AAC.01661-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hammoudi Halat D., Ayoub M.C. The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria. Antibiotics. 2020;9(4):186. doi: 10.3390/antibiotics9040186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Xie L., Dou Y., Zhou K., Chen Y., Han L., et al. Coexistence of blaOXA-48 and truncated blaNDM-1 on different plasmids in a Klebsiella pneumoniae isolate in China. Front Microbiol. 2017;8:133. doi: 10.3389/fmicb.2017.00133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Chukamnerd A., Pomwised R., Phoo M.T.P., Terbtothakun P., Hortiwakul T., et al. In vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand. J Infect Chemother. 2021;27(3):507–514. doi: 10.1016/j.jiac.2020.11.004. [DOI] [PubMed] [Google Scholar]
  • 75.Quale J., Bratu S., Landman D., Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003;37(2):214–220. doi: 10.1086/375821. [DOI] [PubMed] [Google Scholar]
  • 76.Mammeri H., Nordmann P., Berkani A., Eb F. Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett. 2008;282(2):238–240. doi: 10.1111/j.1574-6968.2008.01126.x. [DOI] [PubMed] [Google Scholar]
  • 77.Qu J., Feng C., Li H., Lv X. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. Int J Antimicrob Agents. 2021;57(3) doi: 10.1016/j.ijantimicag.2021.106284. [DOI] [PubMed] [Google Scholar]
  • 78.Piperaki E.-T., Tzouvelekis L., Miriagou V., Daikos G. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect. 2019;25(8):951–957. doi: 10.1016/j.cmi.2019.03.014. [DOI] [PubMed] [Google Scholar]
  • 79.Hrenovic J., Seruga Music M., Durn G., Dekic S., Hunjak B., et al. Carbapenem-resistant Acinetobacter baumannii recovered from swine manure. Microb Drug Resist. 2019;25(5):725–730. doi: 10.1089/mdr.2018.0087. [DOI] [PubMed] [Google Scholar]
  • 80.Bassetti M., Peghin M., Vena A., Giacobbe D.R. Treatment of infections due to MDR Gram-negative bacteria. Front Med. 2019;6(74) doi: 10.3389/fmed.2019.00074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Nie L., Lv Y., Yuan M., Hu X., Nie T., et al. Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm Sin B. 2014;4(4):295–300. doi: 10.1016/j.apsb.2014.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Selasi G.N., Nicholas A., Jeon H., Lee Y.C., Yoo J.R., et al. Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect, Genet Evol. 2015;36:1–7. doi: 10.1016/j.meegid.2015.09.001. [DOI] [PubMed] [Google Scholar]
  • 83.Kuo S.-C., Huang W.-C., Huang T.-W., Wang H.-Y., Lai J.-F., et al. Molecular epidemiology of emerging blaOXA-23-like- and blaOXA-24-like-carrying Acinetobacter baumannii in Taiwan. Antimicrob Agents Chemother. 2018;62(3):e01215–17. doi: 10.1128/AAC.01215-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Pontikis K., Karaiskos I., Bastani S., Dimopoulos G., Kalogirou M., et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents. 2014;43(1):52–59. doi: 10.1016/j.ijantimicag.2013.09.010. [DOI] [PubMed] [Google Scholar]
  • 85.Sirijatuphat R., Thamlikitkul V. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014;58(9):5598–5601. doi: 10.1128/AAC.02435-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Kyriakidis I., Vasileiou E., Pana Z.D., Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021;10(3):373. doi: 10.3390/pathogens10030373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Cheng Y., Yang S., Jia M., Zhao L., Hou C., et al. Comparative study between macrolide regulatory proteins MphR(A) and MphR(E) in ligand identification and DNA binding based on the rapid in vitro detection system. Anal Bioanal Chem. 2016;408(6):1623–1631. doi: 10.1007/s00216-015-9270-5. [DOI] [PubMed] [Google Scholar]
  • 88.Blackwell G.A., Hall R.M. Mobilisation of a small Acinetobacter plasmid carrying an oriT transfer origin by conjugative RepAci6 plasmids. Plasmid. 2019;103:36–44. doi: 10.1016/j.plasmid.2019.04.002. [DOI] [PubMed] [Google Scholar]
  • 89.Nigro S.J., Hall R.M. A large plasmid, p D46–4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii. J Antimicrob Chemother. 2017;72(12):3496–3498. doi: 10.1093/jac/dkx287. [DOI] [PubMed] [Google Scholar]
  • 90.Yoon E.-J., Kim J.O., Yang J.W., Kim H.S., Lee K.J., et al. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017;72(10):2708–2714. doi: 10.1093/jac/dkx205. [DOI] [PubMed] [Google Scholar]
  • 91.Samuelsen Ø., Toleman M.A., Sundsfjord A., Rydberg J., Leegaard T.M., et al. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother. 2010;54(1):346–352. doi: 10.1128/AAC.00824-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Stoesser N., Sheppard A.E., Peirano G., Sebra R.P., Lynch T., et al. First report of blaIMP-14 on a plasmid harboring multiple drug resistance genes in Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2016;60(8):5068–5071. doi: 10.1128/AAC.00840-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Partridge S.R., Kwong S.M., Firth N., Jensen S.O. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31(4) doi: 10.1128/CMR.00088-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.de Nies L., Lopes S., Busi S.B., Galata V., Heintz-Buschart A., et al. PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome. 2021;9(1):1–14. doi: 10.1186/s40168-020-00993-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Liu C., Chang Y., Xu Y., Luo Y., Wu L., et al. Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates. Oncotarget. 2018;9(31):21663. doi: 10.18632/oncotarget.24651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Heath L.S., Heath H.E., LeBlanc P.A., Smithberg S.R., Dufour M., et al. The streptococcolytic enzyme zoocin A is a penicillin-binding protein. FEMS Microbiol Lett. 2004;236(2):205–211. doi: 10.1016/j.femsle.2004.05.038. [DOI] [PubMed] [Google Scholar]
  • 97.Simmonds R.S., Simpson W.J., Tagg J.R. Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin. Gene. 1997;189(2):255–261. doi: 10.1016/s0378-1119(96)00859-1. [DOI] [PubMed] [Google Scholar]
  • 98.Simmonds R., Naidoo J., Jones C., Tagg J. The streptococcal bacteriocin-like inhibitory substance, zoocin A, reduces the proportion of Streptococcus mutans in an artificial plaque. Microb Ecol Health Dis. 1995;8(6):281–292. [Google Scholar]
  • 99.Wintachai P., Naknaen A., Pomwised R., Voravuthikunchai S.P., Smith D.R. Isolation and characterization of Siphoviridae phage infecting extensively drug-resistant Acinetobacter baumannii and evaluation of therapeutic efficacy in vitro and in vivo. J Med Microbiol. 2019;68(7):1096–1108. doi: 10.1099/jmm.0.001002. [DOI] [PubMed] [Google Scholar]
  • 100.Stanczak-Mrozek K.I., Laing K.G., Lindsay J.A. Resistance gene transfer: induction of transducing phage by sub-inhibitory concentrations of antimicrobials is not correlated to induction of lytic phage. J Antimicrob Chemother. 2017;72(6):1624–1631. doi: 10.1093/jac/dkx056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Volkova V.V., Lu Z., Besser T., Gröhn Y.T. Modeling the infection dynamics of bacteriophages in enteric Escherichia coli: estimating the contribution of transduction to antimicrobial gene spread. Appl Environ Microbiol. 2014;80(14):4350–4362. doi: 10.1128/AEM.00446-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Chan A.P., Sutton G., DePew J., Krishnakumar R., Choi Y., et al. A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumannii. Genome Biol. 2015;16(1):1–28. doi: 10.1186/s13059-015-0701-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Antunes L., Visca P., Towner K.J. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71(3):292–301. doi: 10.1111/2049-632X.12125. [DOI] [PubMed] [Google Scholar]
  • 104.Mangas E.L., Rubio A., Álvarez-Marín R., Labrador-Herrera G., Pachón J., et al. Pangenome of Acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation. Microb Genom. 2019;5(11) doi: 10.1099/mgen.0.000309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Rodrigues D.L.N., Morais-Rodrigues F., Hurtado R., Dos Santos R.G., Costa D.C., et al. Pan-resistome insights into the multidrug resistance of Acinetobacter baumannii. Antibiotics. 2021;10(5):596. doi: 10.3390/antibiotics10050596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Hassan A., Naz A., Obaid A., Paracha R.Z., Naz K., et al. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets. BMC Genet. 2016;17(1):1–25. doi: 10.1186/s12864-016-2951-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Kumar P., Sundermann A.J., Martin E.M., Snyder G.M., Marsh J.W., et al. Method for economic evaluation of bacterial whole genome sequencing surveillance compared to standard of care in detecting hospital outbreaks. Clin Infect Dis. 2021;73(1):e9–e18. doi: 10.1093/cid/ciaa512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Quick J., Cumley N., Wearn C.M., Niebel M., Constantinidou C., et al. Seeking the source of Pseudomonas aeruginosa infections in a recently opened hospital: an observational study using whole-genome sequencing. BMJ Open. 2014;4(11) doi: 10.1136/bmjopen-2014-006278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Halachev M.R., Chan J.Z., Constantinidou C.I., Cumley N., Bradley C., et al. Genomic epidemiology of a protracted hospital outbreak caused by multidrug-resistant Acinetobacter baumannii in Birmingham, England. Genome Med. 2014;6(11):1–13. doi: 10.1186/s13073-014-0070-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Stoesser N., Sheppard A., Shakya M., Sthapit B., Thorson S., et al. Dynamics of MDR Enterobacter cloacae outbreaks in a neonatal unit in Nepal: insights using wider sampling frames and next-generation sequencing. J Antimicrob Chemother. 2015;70(4):1008–1015. doi: 10.1093/jac/dku521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Quick J., Ashton P., Calus S., Chatt C., Gossain S., et al. Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella. Genome Biol. 2015;16(1):1–14. doi: 10.1186/s13059-015-0677-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data 1
mmc1.zip (8MB, zip)

Data Availability Statement

The assembled genomes of all 221 CRAB isolates have been deposited in the NCBI GenBank under BioProject number PRJNA752484 with BioSample numbers SAMN20599216 to SAMN20599436.


Articles from Computational and Structural Biotechnology Journal are provided here courtesy of Research Network of Computational and Structural Biotechnology

RESOURCES